Chyba jedyny producent strzykawek i igieł notowany na GPW.

SYRINGES AND HYPODERMIC NEEDLES FOR SINGLE USE
The main materials for the production of syringes are polypropylene, high density polyethylene and a thermoplastic elastomer, which are physiologically harmless. For the packaging is used special paper for sterilization with ethylene oxide and combined film polyamide - polyethylene.
The hypodermic needles are imported in bulk. Packaging and sterilization only of needles or syringes with needles is done by Momina krepost PLC.
The manufacture of syringes is carried out on two technological lines - imported from Germany and Korea.
The equipment consisting of injection molding machines with computer control, printing and assembling and packaging machines has a high degree of mechanization and automation. The details of syringes are produced by the method of injection molding on injection molding machines, then submit to printing and assembling machines to print the scale and assembly of the syringes. Finished products are packaged on packaging machines for blister packaging.
The capacity of the production equipment is 100 million pieces syringes annually with a capacity of 1 ml, 2 ml, 5 ml, 10 ml, 20 ml and 50 ml, with and without needles, only needles – 20 million pieces.

a tu oferta ich spółki zależnej:
https://www.mkrepost-bg.com/index.php?mod=catalog&show=25

tylko czy będą mieli wystarczające moce produkcyjne żeby zaspokoić popyt ...

Maarc, ten tekst to z jakiego źródła?

Raport za q3

Znalazłem takie źródło. Coś grubszego się tutaj kroi... wolumen rośnie, dzisiaj i w piątek sesje z największymi obrotami od 2016.

https://www.sopharmagroup.com/en/business/non-pharma-activities

Arkusz zleceń po stronie sprzedaży jakby się trochę przerzedził...

https://www.bankier.pl/wiadomosc/SOPHARMA-AD-Preliminary-individual-annual-financial-statements-of-Sopharma-AD-for-2020-8048237.html